<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04207372</url>
  </required_header>
  <id_info>
    <org_study_id>NL63446.081.17</org_study_id>
    <nct_id>NCT04207372</nct_id>
  </id_info>
  <brief_title>Protein Digestibility of Whey and Zein.</brief_title>
  <official_title>Determination of Protein Digestibility of Whey and Zein in Ileostomates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massey University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Global Dairy Platform Incorporated</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The evaluation of protein quality has top priority according to Food and Agricultural&#xD;
      Organization of the United Nations. However, one aspect of protein quality, namely the&#xD;
      digestibility of protein is largely unknown. A database on this matter is lacking as it is&#xD;
      difficult to measure ileal digestibility in humans.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: This study aims to determine the digestibility of amino acids in two protein&#xD;
      sources in men and women with normally functioning ileostomies.&#xD;
&#xD;
      Study design: Intervention study with 6 test days, testing 3 meals each twice. Study&#xD;
      population: Eight men and women with normally functioning ileostomies will be recruited for&#xD;
      the study.&#xD;
&#xD;
      Intervention: On six separate test days, subjects will receive a meal, consisting of a drink&#xD;
      and biscuit. With this, two different protein containing meals, i.e. zein and whey, and a&#xD;
      protein-free meal is tested; these three treatments are given at two occasions, thus in total&#xD;
      6 meals are tested. After consumption of the meal, subjects collect their digesta for nine&#xD;
      hours.&#xD;
&#xD;
      Main study parameters/endpoints: Ileal amino acid digestibility of zein and whey protein&#xD;
      isolate.&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation, benefit and group&#xD;
      relatedness: The subject will not benefit from the study except for the contribution to&#xD;
      scientific research. The risk of participating to this study is low, some gastrointestinal&#xD;
      discomfort could occur. Subjects have to come to the research facility seven times, a&#xD;
      screening visit of 1 hour, and 6 experimental days of 10 hours. Subjects will be financially&#xD;
      compensated for participation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 4, 2018</start_date>
  <completion_date type="Actual">January 17, 2019</completion_date>
  <primary_completion_date type="Actual">January 17, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Intervention study with 6 test days, testing 3 meals each twice</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Allocation of different proteins(or no protein) is blinded from participant.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>the ileal amino acid digestibility of Zein and Whey Protein Isolate</measure>
    <time_frame>9 hours per day</time_frame>
    <description>ileal digesta samples are collected in the nine hours after consumption of these proteins and after consumption of a protein-free diet.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Biological Availability</condition>
  <arm_group>
    <arm_group_label>Whey protein isolate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Zein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein-free</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>whey protein isolate</intervention_name>
    <description>whey protein isolate</description>
    <arm_group_label>Whey protein isolate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zein</intervention_name>
    <description>zein protein</description>
    <arm_group_label>Zein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>protein-free</intervention_name>
    <description>protein free</description>
    <arm_group_label>Protein-free</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Age between 18 and 60&#xD;
&#xD;
          -  Willing to eat animal protein&#xD;
&#xD;
          -  Have a well-established and normally functioning terminal ileostomy, with stomal&#xD;
             faeces of normal physiological consistency&#xD;
&#xD;
          -  Good general health, meaning subjects should be well-recovered from the ileostomy&#xD;
             operation, their underlying disease should be cured or in remission and they should&#xD;
             not have any other major health problems&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taken antibiotics or medication that majorly impair small intestinal digestion and&#xD;
             absorption within eight weeks of participating in the study.&#xD;
&#xD;
          -  Have been pregnant or breastfeeding in the last 12 months, or plan to become pregnant&#xD;
             during the study&#xD;
&#xD;
          -  Having renal impairment, coeliac disease or diabetes&#xD;
&#xD;
          -  Drug abuse&#xD;
&#xD;
          -  Alcohol consumption of &gt;14 units per week.&#xD;
&#xD;
          -  Having an allergy or intolerance to dairy, corn products or fructose&#xD;
&#xD;
          -  Currently taking protein supplements and would not be willing to stop using these&#xD;
             during the study&#xD;
&#xD;
          -  Being on a controlled diet or dietary weight loss regimen during the two weeks prior&#xD;
             to the start of this study and/or during the study&#xD;
&#xD;
          -  Personnel of division of Human Nutrition, Wageningen University..&#xD;
&#xD;
          -  Current participation in other research from the Division of Human Nutrition&#xD;
&#xD;
          -  Not having a general practitioner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Division of Human Nutrition, Wageningen University</name>
      <address>
        <city>Wageningen</city>
        <state>Gelderland</state>
        <zip>6703 HA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 28, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wageningen University</investigator_affiliation>
    <investigator_full_name>Geleijnse</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Digestibility</keyword>
  <keyword>Whey</keyword>
  <keyword>Zein</keyword>
  <keyword>Protein</keyword>
  <keyword>Ileostomates</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

